The Board of Directors on recommendation of the ESOP Compensation Committee of the Board of Directors of the Company has allotted 217,850 Equity shares of Rs.1/- each of the Company, fully paid-up, on January 22, 2021 to employees on exercise of their stock options pursuant to Gland Pharma Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 163,500,673/- comprising of 163,500,673 Equity shares of face value Rs. 1/- each.
Gland Pharma Ltd - 543245 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 037370 Name of the Signatory :- p sampath kumarDesignation :- Company Secretary and Compliance Officer